What if AI could catch the lung cancer your doctor missed?
New data presented at ARRS 2026 stopped the radiology community in its tracks. An FDA-cleared AI platform demonstrated the ability to detect lung cancers on chest X-rays that were retrospectively confirmed to have been missed by human radiologists — cancers that were present on prior imaging but not identified until they had progressed to a more advanced stage.
📊 The numbers are significant. Lung cancer remains the leading cause of cancer death in the United States, killing approximately 125,000 Americans per year. The five-year survival rate for stage I lung cancer exceeds 80 percent. For stage IV, it drops below 10 percent. The difference between those outcomes is almost entirely a function of when the cancer is detected. Every missed finding on a prior chest X-ray represents a patient whose survival odds deteriorated while the cancer grew undetected.
The ARRS data adds to a growing body of evidence that AI-assisted chest X-ra…
